{
    "title": "Reuters Health News Summary",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11458873/Reuters-Health-News-Summary.html",
    "date": "2022-11-22",
    "keywords": [
        "health",
        "tuesday",
        "cancer",
        "drug",
        "vaccine",
        "covid19",
        "study",
        "house",
        "inc",
        "protection",
        "blenrep",
        "state",
        "therapy",
        "china",
        "city",
        "shot",
        "briefing",
        "official",
        "response",
        "disease",
        "blood",
        "company",
        "month",
        "goal",
        "treatment",
        "abbvie",
        "crisis",
        "alliance",
        "combination",
        "latestage",
        "chemotherapy",
        "monkeypox",
        "world",
        "jha",
        "claim",
        "agreement",
        "summary",
        "news",
        "entry",
        "covid",
        "shut",
        "shanghai",
        "spike",
        "concern",
        "economy",
        "reopening",
        "peak",
        "april",
        "guangzhou",
        "municipality",
        "accounting",
        "dr",
        "anthony",
        "face",
        "countrys",
        "division",
        "promote",
        "president",
        "joe",
        "adviser",
        "flu",
        "ebola",
        "gsk",
        "setback",
        "business",
        "market",
        "approval",
        "food",
        "administration",
        "fda",
        "marketing",
        "july",
        "teva",
        "supply",
        "naloxone",
        "sprawling",
        "litigation",
        "phase",
        "corp",
        "walmart",
        "keytruda",
        "type",
        "combo",
        "improvement",
        "standalone",
        "drugmaker",
        "britain",
        "dose",
        "virus",
        "england",
        "evidence",
        "effectiveness",
        "organisation",
        "emergency",
        "level",
        "platform",
        "role",
        "misinformation",
        "responsibility",
        "disinformation"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}